Hosenkoside B exhibits significant anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6 in cellular models. It has been studied for its potential use in managing chronic inflammatory conditions, including arthritis and inflammatory bowel disease. Research also suggests neuroprotective properties, where it reduces oxidative stress and microglial activation in neuronal cell cultures, indicating possible application in neurodegenerative disorders like Alzheimer’s disease. Additionally, it shows moderate antiviral effects against certain enveloped viruses by interfering with viral entry into host cells. Due to its natural origin and low cytotoxicity, it is being explored as a lead compound for developing safer therapeutic agents.